Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaven Grwth 3 Regulatory News (MIG3)

Share Price Information for Maven Grwth 3 (MIG3)

Share Price is delayed by 15 minutes
Get Live Data
42.40    0.00 (0.00%)
Bid:
41.40
Ask:
43.40
Spread: 2.00 (4.831%)
Market Cap: £65.92m
MIG3 Live PriceLast checked at - London Stock Exchange

Intraday Maven Grwth 3 Share Chart

Statement re NAV and Final Dividend

4 Feb 2022 09:45

RNS Number : 7485A
Maven Income and Growth VCT 3 PLC
04 February 2022
 

Maven Income and Growth VCT 3 PLC

 

Net Asset Value and Proposed Final Dividend

 

The Directors of Maven Income and Growth VCT 3 PLC ("the Company") confirm that the unaudited net asset value of the Company as at 30 November 2021 was 62.55p per Ordinary Share.

 

The Directors propose that a final dividend of 1.50p per Ordinary Share, in respect of the year ended 30 November 2021, be paid on 26 April 2022 to Shareholders on the register at close of business on 25 March 2022.

The Company has in place a Dividend Investment Scheme (DIS) through which Shareholders may elect to have their dividend payments used to apply for new Ordinary Shares issued by the Company under the standing authority requested from Shareholders at Annual General Meetings. Shares issued under the DIS should qualify for VCT tax reliefs applicable for the tax year in which they are allotted. Terms & conditions of the scheme, together with a mandate form, are available from the Company's website at: www.mavencp.com/migvct3.

Shareholders who have not previously applied to participate in the DIS and who wish to do so in respect of the dividend payable on 26 April 2022, should ensure that a mandate form is received by the Registrar, The City Partnership (UK) Limited, prior to the dividend election date of 8 April 2022.

 

Further to the information disclosed above, the Directors confirm that they are satisfied that all inside information (as defined by Article 7 of the Market Abuse Regulation (596/2014/EU)) that the Directors and the Company may have in their possession relating to the Company during the 30 day closed period leading up to the announcement of its annual results for the year ended 30 November 2021 has been or will be notified to a regulatory information service.

 

Issued on behalf of the Board

Maven Capital Partners UK LLP

Secretary

4 February 2022

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
STRFIFVAFAISIIF
Date   Source Headline
11th Aug 20144:22 pmRNSTransaction in Own Shares
4th Aug 20145:26 pmRNSDirector/PDMR Shareholding
31st Jul 20143:06 pmRNSDirector/PDMR Shareholding
31st Jul 20143:03 pmRNSTransaction in Own Shares
29th Jul 20143:44 pmRNSDirector/PDMR Shareholding
29th Jul 201412:37 pmRNSHalf Yearly Report
4th Jul 20144:31 pmRNSReplacement re Issue of Equity
2nd Jul 20149:50 amRNSIssue of Equity
28th May 20145:09 pmRNSOffer for Subscription Update
30th Apr 20142:25 pmRNSDirectorate Change
30th Apr 20142:18 pmRNSAGM Results
30th Apr 20147:01 amRNSStatement re Offer for Subscription
24th Apr 20142:46 pmRNSOffer for Subscription - Supplementary Prospectus
15th Apr 201410:09 amRNSInterim Management Statement
7th Apr 20144:16 pmRNSOffer for Subscription - Supplementary Prospectus
7th Apr 201411:29 amRNSIssue of Equity
18th Mar 20147:00 amRNSOffer for Subscription - Supplementary Prospectus
4th Mar 20143:56 pmRNSAnnual Financial Report
13th Feb 201410:42 amRNSDirector/PDMR Shareholding
10th Feb 20146:05 pmRNSOffer for Subscription - Supplementary Prospectus
5th Feb 20144:20 pmRNSIssue of Equity
3rd Jan 201411:09 amRNSDirectorate Change
27th Nov 20132:04 pmRNSReplacement Result of General Meeting
27th Nov 20131:33 pmRNSResult of EGM
24th Oct 20136:11 pmRNSOffer for Subscription
17th Oct 20132:39 pmRNSInterim Management Statement
25th Sep 201311:33 amRNSStatement re Proposed Joint Fund Raising
30th Aug 20133:34 pmRNSTransaction in Own Shares
29th Aug 20134:11 pmRNSTransaction in Own Shares
27th Aug 20133:56 pmRNSTransaction in Own Shares
23rd Aug 201312:42 pmRNSTransaction in Own Shares
22nd Aug 20133:07 pmRNSTransaction in Own Shares
20th Aug 20132:59 pmRNSTransaction in Own Shares
16th Aug 20132:53 pmRNSTransaction in Own Shares
15th Aug 20133:07 pmRNSTransaction in Own Shares
12th Aug 20131:21 pmRNSTransaction in Own Shares
15th Jul 20134:32 pmRNSHalf Yearly Report
18th Jun 20132:22 pmRNSChange of Registered Office
10th May 20135:59 pmRNSTransaction in Own Shares
7th May 20134:24 pmRNSTransaction in Own Shares
2nd May 20135:18 pmRNSDirector/PDMR Shareholding
2nd May 20135:16 pmRNSDirector/PDMR Shareholding
2nd May 20135:10 pmRNSDirector/PDMR Shareholding
2nd May 20135:04 pmRNSInterim Management Statement
1st May 20133:21 pmRNSResult of AGM
26th Apr 20132:57 pmRNSIssue of Equity
10th Apr 20133:11 pmRNSTransaction in Own Shares
9th Apr 201312:47 pmRNSTransaction in Own Shares
8th Apr 20131:52 pmRNSTransaction in Own Shares
8th Apr 20137:00 amRNSIssue of Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.